# FDA Inspection 1053977 - Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. - May 11, 2018

Source: https://www.keypedia.com/records/fda_inspections/hangzhou-minsheng-binjiang-pharmaceutical-co-ltd/2021e6ab-df12-4df3-8967-3f72bfa61edd
Source feed: FDA_Inspections

> FDA Inspection 1053977 for Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. on May 11, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1053977
- Company Name: Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
- Inspection Date: 2018-05-11
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1265022 - 2025-03-07](https://www.keypedia.com/records/fda_inspections/hangzhou-minsheng-binjiang-pharmaceutical-co-ltd/9173306d-cce2-4074-a429-0c5f2e571d00)
- [FDA Inspection 990181 - 2016-07-29](https://www.keypedia.com/records/fda_inspections/hangzhou-minsheng-binjiang-pharmaceutical-co-ltd/97923d47-e3d6-4e95-ab1f-fb4ed076a382)
- [FDA Inspection 879374 - 2014-04-25](https://www.keypedia.com/records/fda_inspections/hangzhou-minsheng-binjiang-pharmaceutical-co-ltd/8e1cd16c-186c-4866-bcbb-b65bada4619c)
- [FDA Inspection 732327 - 2011-06-10](https://www.keypedia.com/records/fda_inspections/hangzhou-minsheng-binjiang-pharmaceutical-co-ltd/513ec2c5-8110-43d8-bda5-858e6ea1d197)

Company: https://www.keypedia.com/companies/hangzhou-minsheng-binjiang-pharmaceutical-co-ltd/60558281-5fe9-47ef-a772-a976c821d6b2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c